The PE Ratio as of November 2024 (TTM) for Centessa Pharmaceuticals plc (CNTA) is -11.21

According to Centessa Pharmaceuticals plc’s latest financial reports and current stock price. The company's current PE Ratio is -11.21. This represents a change of 54.96% compared to the average of -7.23 of the last 4 quarters.

Centessa Pharmaceuticals plc (CNTA) Historical PE Ratio (quarterly & annually)

How has CNTA PE Ratio performed in the past?

The mean historical PE Ratio of Centessa Pharmaceuticals plc over the last ten years is -116.14. The current -11.21 PE Ratio has changed 865.21% with respect to the historical average. Over the past ten years (40 quarters), CNTA's PE Ratio was at its highest in in the March 2020 quarter at 0. The PE Ratio was at its lowest in in the September 2020 quarter at -361.29.

Centessa Pharmaceuticals plc (CNTA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Centessa Pharmaceuticals plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Centessa Pharmaceuticals plc (CNTA) Average PE Ratio

How has CNTA PE Ratio performed in the past?

The current PE Ratio of Centessa Pharmaceuticals plc (CNTA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Centessa Pharmaceuticals plc (CNTA) PE Ratio vs. Peers

How is CNTA’s PE Ratio compared to its peers?

Centessa Pharmaceuticals plc’s PE Ratio is less than Century Therapeutics, Inc. (-0.79), greater than Edgewise Therapeutics, Inc. (-24.30), less than C4 Therapeutics, Inc. (-2.80), less than Mineralys Therapeutics, Inc. (-4.06), less than Cullinan Oncology, Inc. (-5.10), less than NewAmsterdam Pharma Company N.V. (-10.06), less than Sutro Biopharma, Inc. (-1.66), less than Opthea Limited (-1.15), less than HilleVax, Inc. (-0.61), greater than Nuvalent, Inc. (-27.80), greater than Tarsus Pharmaceuticals, Inc. (-13.78), less than Genfit S.A. (141.32), greater than Gracell Biotechnologies Inc. (-29.05), less than Theseus Pharmaceuticals, Inc. (-6.29), less than Monte Rosa Therapeutics, Inc. (-5.83), less than Design Therapeutics, Inc. (-6.66), less than Erasca, Inc. (-4.79), greater than Crinetics Pharmaceuticals, Inc. (-16.16), less than Entrada Therapeutics, Inc. (13.90), greater than Disc Medicine, Inc. (-18.79), less than Larimar Therapeutics, Inc. (-6.07),

Build a custom stock screener for Centessa Pharmaceuticals plc (CNTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Centessa Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Centessa Pharmaceuticals plc (CNTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Centessa Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.